Optical image-guided cancer surgery is a promising technique to adequately determine tumor margins by tumor-specific targeting, potentially resulting in complete resection of tumor tissue with improved survival.
Introduction
For cancer surgery with curative intentions, radical resection (i.e., removal of all cancer cells) is a sine qua non. In order to achieve this, the surgeon has to adequately assess the tumor resection margin during the operation. Optical molecular imaging using near-infrared (NIR) fluorescence introduces a revolutionary new approach to address this basic challenge in surgical oncology. Preclinically, optical imaging has been employed in tumor identification; image-guided resection; therapy monitoring; and detection of sentinel lymph nodes. Because tumor-specific agents were not yet approved for clinical use, the first clinical studies were performed using non-specific fluorescent agents that had long been approved for different applications and could therefore be used for sentinel lymph node mapping. (6, 7) Clinical trials of tumor imaging using indocyanine green have been reported in hepatobiliary and colorectal cancer. (8) Recently, a milestone step was completed when the first in-human trial was reported using tumor-specific targeting, (9) marking the beginning of a new phase of optical image-guided surgery.
However, although it is very likely that the technique will deliver an important contribution to surgical oncology, there are fundamental limitations to this approach that influence the ability to differentiate the targeted tissue from its surroundings. Now that the first clinical trial has been reported, the group of Author Manuscript Published OnlineFirst on May 14, 2013; DOI: 10.1158/1078-0432.CCR- oncologic surgeons that gets acquainted with the flourishing field of optical image-guided surgery is increasing day by day, with clinical consequences at stake. As we will show, it is essential for the clinician to understand which phenomena occur when photons travel through tissues and how these phenomena influence the optical image that is acquired. We therefore believe that it is now, more than ever, of paramount importance to provide the surgical oncologist a clear overview of the basic principles of optical image-guided surgery in order to be able to understand how these limitations influence the sensitivity of this technique. Awareness of these limitations and focusing research on solving these challenges is of utmost importance for proper implementation and evaluation of the clinical value of this new technology.
The basic principle of fluorescence imaging
The geometrical principle of fluorescence imaging is illustrated in Figure 1a . A light source is required that sends out a bundle of light with a specific wavelength that is able to excite the fluorophore (i.e., excitation photons). Because the targeted fluorophore is located under the tissue surface, this excitation light has to enter and travel through tissue to reach the fluorophore. Light entering the tissue is partly influenced by reflection and refraction at the tissue surface. The direction of photons that travel through the tissue can be changed due to scattering. In addition, photons can be absorbed by various components in the tissue. Only when such a component is a fluorophore, which can be either an intrinsic tissue component (i.e., autofluorescence) or an injected external fluorescent agent, absorption of a photon results in a gain in energy of the fluorophore which then enters an excited state (Figure 1b) . The electrons remain in this state for about 10 −8 seconds depending on the molecule, which is called the lifetime of the fluorophore. After this phase, the system returns to its ground state and emits the photon, which could be heading into all directions ( Figure 1b) . The change in energy between the absorbed and the emitted photon results in a change in wavelength. This shift of shorter wavelengths (higher energy) of the absorption spectrum to longer wavelengths (lower energy) of the emitted fluorophores is called the Stokes shift. After excitation of the fluorophore, emission photons will also be influenced by scattering and absorption, and the photons that reach the tissue surface will subsequently be influenced again by reflection and refraction at the surface.
Finally, in a clinical geometry, only part of these photons can eventually be detected by the camera system.
Research. Although optical imaging is based on the detection of photons, Figure 2 illustrates that the path that photons travel through the imaged tissue is influenced by optical properties of the components in the tissue (i.e., absorption and scattering). As a result, fluorescence images will display intensities that are strongly influenced by varying absorption properties of the tissue and the images may be blurred due to scattering of light. The following paragraphs explain in detail how these phenomena influence the acquired image.
What happens when light travels through tissue?

Absorption
All tissues contain components that can absorb photons that travel through them. The composition of these components varies between different tissue types and organs, but also within these tissues, and may vary in time. (10) In general, the most relevant absorbers of photons are water, lipids, oxyhemoglobin and deoxyhemoglobin ( Figure 3a) . (11) Blood is the main absorber in the visible region, and the absorption of light by blood is the highest in the blue-green region. This fact can be illustrated by illuminating the human skin with white light. Due to absorption of photons with shorter wavelengths, a reddish reflection returns from the skin. In this way, absorbers influence the color of the light that exits imaged tissues. In the NIR range, the absorbance per volume of these components is much lower than in other parts of the spectrum, allowing for deeper penetration of photons into the tissue (Figure 3 ).
Scattering
Next to absorption of the photon, a change in photon direction can occur, an effect known as scattering ( Figure 4) . In most part of the visible and NIR region, scattering events occur much more frequently than absorption events. Even though a forward direction of scattering photons is most likely to occur in tissues, the accumulation of multiple consecutive scatter events will result in a gradual randomization of the propagation direction (i.e., diffuse light, Figure 4 scattering tissue, the contorted light path causes retention of photons in that specific area. In other words, in a highly scattering medium, the photons bounce around locally for a longer time, increasing the chance for a fluorescence event. Consequently, there can be increased fluorescence intensity in tissues with more scattering compared to tissues with less scattering. (13) The net effect of scattering on fluorescence imaging depends on the exact optical properties of the tissue at hand.
Influence of optical properties on light penetration depth
Scattering and absorption coefficients vary between locations and tissues due to the different components within the heterogeneous tissue. Importantly, the influence of these phenomena on the fluorescence signal will be higher when fluorescent light has to emerge from larger tissue depths and consequently has to pass more absorbers and scattering events. In the visible light region, absorption by biological chromophores limits the penetration depth to a few millimeters with a maximum of 10 millimeter. Due to less absorption and scattering, penetration depth is increased to more than a centimeter in the NIR region, (14) , (15) however strongly depending on the type of tissue.(1, 3, 16) ( Figure 5 ).
Reflection and refraction
As imaging during surgery always focuses on a surface, the mismatch between the indices of refraction of tissue and air is unavoidable, resulting in a change in direction of the photons. This mismatch in index of refraction causes reflections to occur at the surface. The excitation light will be partially reflected from the surface, like the sun on a water surface. When the light is nearly perpendicular to the surface of the tissue, the surface reflection is not more than a few percent. However, emitted fluorescent light that is generated inside the tissue is diffuse, and partly reaches the surface under large angles resulting in complete reflection within the tissue. This internal diffuse reflection coefficient at the surface can be in the order of 50%.
Consequently, the emitted fluorescent light is even more diffuse and the amount of light that escapes the surface and can be detected by the fluorescence camera is further decreased.
Fluorescence imaging and autofluorescence
Research. Because we can see cancerous lesions with our eyes, the optical properties of these lesions are changed by definition, and a difference in autofluorescence signal compared to the surroundings can be detected.
This effect has been used for autofluorescence-guided surgery. (17) However, due to the aforementioned effects, "tumor-specific" autofluorescence signals can vary over time, making it an unreliable target. are consistently reported, they can be used to aid the surgeon in assessing the tumor margins, but should not be considered as tumor-specific proof of tumor margins.
As a good alternative, a target-specific agent that contains a fluorophore is usually injected intravenously. Now that we understand how optical properties can influence the optical path of the photon, we are confronted with a second challenge: how can we determine if the photon that we detect has been excited by the targeted fluorophore, and not by its surrounding autofluorescent components?
For the targeted cancer cells to be detected, the signal of the target-specific fluorescence agent must be significantly higher than the non-specific autofluorescence. Although autofluorescence is much lower when NIR light is used, the signal-to-background ratio (SBR) must be sufficient in order to distinguish the photons of the target-specific fluorescent agent from the autofluorescence signal. 
Strategies to reduce the influence of absorption and scattering on the image
With the state of the art technological advancements, it remains impossible to determine all absorbers and scatter events within a diffuse, inhomogeneous medium. However, calculation methods have been developed that try to estimate the perturbation caused by optical tissue properties and improve the image by partly correcting for these properties. (14) An intraoperative fluorescence imaging system has been developed that implements such a correction scheme for light intensity variation in tissues. variation in tissues. At a five-fold change of absorption variation within the fluorescent lesions, quantification errors were reduced from 25% in uncorrected images to 8% using the correction scheme. (21) A second new technology that is investigated in this field is fluorescence differential path length spectroscopy, which determines fluorophore concentration based on the fluorescence intensity corrected for absorption. (22) This facilitates quantitative concentration measurements even for strong variations in either background absorption or scattering. However, this method can currently only be performed using fiberoptic measurement at a single point. An imaging version and subsequent intraoperative applications have not been developed yet. Finally, tomographic reconstruction techniques (23) Raman spectroscopy (24) and photoacoustic imaging (12, 25) may play important future roles, although currently not suited for realtime imaging in the surgical theatre. Raman spectroscopy is based on inelastic scattering: the effect on the frequency of excitation photons that changes upon interaction with tissue, which is independent of optical tissue properties or autofluorescence. (24, 26) In surface-enhanced Raman spectroscopy (SERS), tumorspecific nanobodies are injected that are able to increase the intrinsically very low Raman effect, thereby improving detectability. Promising preclinical results of brain tumor resection guided by SERS have been reported. (27) In photoacoustic imaging (also referred to as optoacoustic imaging), thermoelastic expansion of molecules resulting from laser pulse irradiation causes emission of acoustic waves that can be measured by photoacoustic spectroscopy. The resolution in photoacoustic imaging is not limited by tissue scattering but by the attenuation of acoustic frequencies by tissue. (12, 25) This technique improves deep-tissue imaging, but is less suitable for image-guided surgery.
Strategies to distinguish the target-specific fluorescence signal from autofluorescence
There are currently two methods under investigation that attempt to separate the target-specific fluorescence signal from the non-specific autofluorescence. The first is based on differences in the fluorescence spectrum between photons from these two fluorescent sources (i.e., spectral unmixing), and the second method exploits differences in fluorescence lifetime of the fluorophores (i.e., lifetime imaging).
The concept of spectral unmixing is based on the "signature" emission intensity that each fluorophore has at certain wavelengths, providing the fluorophore with its own specific emission spectrum. (28) 
spectral unmixing, the signal is decomposed into a collection of predefined spectra that is used to determine the individual contribution of each fluorophore. Using calculation models combined with the fluorophore specific emission spectrum as reference (i.e., linear unmixing), the contribution of each fluorophore in a total fluorescent signal can be extracted. (29) When spectral signatures of the fluorophore of interest and the autofluorescence are known, unmixing these specific fluorescence spectra may result in a more accurate SBR. The first in-human trial on intraoperative tumor-specific fluorescence imaging was performed using a camera system that was based on spectral unmixing technology. (9, 21) There are however fundamental problems with this approach. Linear unmixing is based on the assumption that the measured spectrum consists of the sum of the fluorescence spectra of all the components in the tissue, i.e., linear mixing. As mentioned earlier, inhomogeneous optical properties influence the path that photons travel through the imaged tissue and therefore not only put their own signatures on the fluorescence spectrum, but may also do so non-linearly because of the inhomogeneous nature of tissue. Furthermore, the unmixing procedure is a very complex process that requires that all components that contribute to the spectrum are known, as well as all of their specific "signature" spectra, which also need to be sufficiently distinctive from one another.
The second method, fluorescence lifetime imaging, distinguishes individual fluorophores by their specific temporal decay after excitation. This fluorescence decay (i.e., lifetime) is a fluorophore-specific characteristic that is not influenced by the local concentration of fluorophores, the optical path, the local excitation intensity, or the local fluorescence detection efficiency. To acquire the characteristic decay curves, a picosecond laser pulse is used for excitation and fluorescence is measured as a function of time.
Based on the specific lifetime of the fluorophores, the target-specific fluorescence signal can be distinguished from the non-specific autofluorescence. In addition, the temporal response at which photons emerge from the tissue can be measured (i.e., time-domain imaging), which is used to estimate the concentration and depth of the fluorescent source. Lifetime imaging requires specific conditions in terms of pulsed excitation and data capturing with complex data processing, which currently makes it a timeconsuming technique. Although intraoperative lifetime based techniques are being developed at a strong pace and hold promising advantages, it will take some time before they can be used in a real-time intraoperative setting where mobility of the equipment and speed of data processing and interpretation are of the essence. (30) Research. 
What is required for a target-specific fluorescence image?
So far, we have assumed that the fluorescent agent has been able to specifically target the tissue of interest with subsequent co-localization between the fluorescent signal and tumor cells. However, in order to gain a complete insight into the different phenomena that can influence the optical image, it is necessary to understand the challenges of tumor-specific targeting.
Based on the hallmarks of cancer,(31) a growing variety of tumor-specific targets are available for imaging of cancer. (2) The efficiency of target-specific agents to reach their intended target is defined by many variables, including affinity of the agent and abundance of the target receptors or epitopes.(16) In order to achieve target-specific fluorescence imaging, the contrast agent has to be delivered to the target, requires adequate contact time with the target for binding to occur, and has to be retained by the target while non-bound agents are cleared from the circulation.(10) It has been reported that at saturating doses of the agent, high affinity antibody uptake is dependent on antigen expression levels. However, at subsaturating doses, the signal is generally limited by delivery of the agent. (32) For the agent to be effectively delivered to the target, many barriers in the human body have to be passed. Next to inhibitor proteins present in plasma that can non-specifically bind to the agent,(1) walls of blood vessels provide a first barrier for drug delivery to targeted tumor tissues. In most cases, abnormal neovascularization of the tumor occurs (i.e., enhanced permeability and retention (EPR) effect) resulting in leaky tumor blood vessels. 
How relevant is all this for the clinical practice of surgical oncology?
Optical imaging is a complicated process. In order to adequately interpret the intraoperative fluorescent image of the tumor that is presented, the surgeon should comprehend that the target-specific fluorescent agent had to get to and stay at the tumor, that part of the signal was reduced and distorted by absorbers and scatter events, and that the signal had to be subtracted from its autofluorescent surroundings. Considering all these influences that could hamper detection of cancer cells that are located under the surface, the additional value of NIR fluorescence imaging over conventional surgery could be questioned. After all, after a mere three decades of extensive research, the fundamental principles of optical imaging still leave room for error and it currently seems that this approach will never be unambiguous.
In order to determine the additional value of intraoperative optical imaging, we need to ask ourselves what the fundamental purpose of this tool should be for surgical oncology. In essence, the goal of surgery is Moreover, in some cases that have thin tumor strands that are invisible to the naked eye, a tumor-free margin of up to several centimeters is required for local control using conventional surgical practice.
Although effects of scattering could result in a fluorescent halo of up to several millimeters under certain conditions, detection of these tumor strands using optical imaging would still largely reduce the need of these large tumor-free margins, resulting in improved postoperative functionality. Although yet to be proven in large clinical trials, it is anticipated that this will already lead to a decrease in local recurrence rate and improved patient survival and functionality.
Secondly, it has been suggested that penetration depth limitations might not be relevant for surgical practice because the surgeon will, by definition, bring the area of interest closer to the surface during the surgical procedure.(34, 43) When, after resection of the tumor mass, an area is found with persisting fluorescence signal indicating irradical margins, this could be resected subsequently until no more signal is found in a "cut the light-procedure", similar to the technique of Mohs surgery. Although a similar procedure, optical imaging will be much more efficient than Mohs surgery due to real-time acquisition and the fact that intraoperative pathological evaluation is not required. At the surface, the influence of optical properties will be minimized, improving the sensitivity even in cases of perineural or perivascular growth, as long as the photons from the contrast agent can be differentiated from autofluorescence. Finally, although it is currently impossible to completely correct for an unknown variability in optical properties of the tissue, we should not forget that there is a very advanced system available that is highly capable of identifying distinct tissue components (e.g. blood vessels) during the surgical process: the surgeon itself. The true additional value of this technique will become clear once the surgical expertise to distinguish tissue components becomes incorporated into the interpretation of the images. For example, the surgeon would preferable reinvestigate a suspicious region that has no fluorescence signal if it is covered by a blood vessel as long as the surgeon realizes that vessels can be highly absorbent. Using the knowledge about the tissues at hand, optical image-guided surgery will result in a dynamic and flexible process providing the surgeon with valuable additional information during the entire operation. This will likely require a learning curve that would follow the encouraging example of pioneer work in resection of malignant gliomas using 5-aminolevulinic acid. Preliminary intraoperative studies in this field provide detailed reports on these learning processes. (44, 45) These showed that photons are highly absorbed by blood or cauterized tissue debris after monopolar cautery resection and that suction of these layers or rinsing the surface with saline is required for unperturbed assessment of tissue fluorescence. Furthermore, necrotic tumor centers accumulated little fluorescence, which was not a problem because necrosis could easily be distinguished under white light and therefore did not impair fluorescence-guided tumor resection.
Tissues were not falsely labeled by fluorescence from blood contaminating the tumor cavity, which might have been expected if plasma had contained substantial amounts of fluorescent agent. Photobleaching after overexposure was minimized with improved development of fluorophores. Finally, the fluorescent source could be located by manipulation of the tissues as illustrated in Figure 5 . The success of this approach has led to a randomized controlled multicenter phase-III trial demonstrating improved progression-free survival in patients with malignant glioma using fluorescence-guided surgery. (46) What level of accuracy is required for the routine of surgical practice?
Considering the intraoperative flexibility of a trained surgeon and the practice of exploration of the area of interest during surgery, we believe that optical image-guided surgery has the potential to largely reduce the tumor-free safety-margin. If a tumor-free margin around the tumor could be minimized, 
postoperative functional outcome could be drastically improved in many cases where the tumor is surrounded by important anatomical structures. This would require tumor imaging with optimal sensitivity and specificity of the tumor-specific agent, followed by resection of the fluorescent tissue without any excess margin of healthy tissue. It is anticipated that sensitivity and specificity of the target-specific agent will be optimized by simultaneously targeting multiple tumor characteristics at different wavelengths. (42, 47) In order to adequately assess the fluorescent border, high accuracy of the imaging technique is demanded. This would require high-resolution images that can be acquired at higher magnifications than the regular macroscopic field of view. Although not suitable for intraoperative use, a system that incorporates both macroscopic and microscopic imaging has been tested in an experimental setting of cancer detection.(23) In the macroscopic field of view, the smallest lesion detectable with a highly expressed antigen (e.g., several million antigens/cell) was approximately 600 μm, a volume that approaches pixel resolution of the macroscopic images (110 μm/pixel). Higher magnification of this tumor revealed images down to the single cell level due to higher resolution. (23) These results suggest that incorporation of zoom-function into the intraoperative camera system would improve surgical accuracy by using a combination of macroscopic imaging (to survey the tissue and guide tumor resection) and microscopic imaging (to verify clean resection margins).(40) However, scattering generally determines the sharpness of the in vivo fluorescence image, especially for deeply located fluorescent sources, and not the imaging equipment. Furthermore, microsurgical or robotic camera systems are only used in some oncological surgical specialties (e.g. neurosurgery). Therefore, in daily routine and logistics of surgical practice in most other cases, the tremor of the surgical hand will limit removal of the tumor with accuracy smaller than 0.5 mm. As a result, the accuracy of removing the fluorescent tissue will not only be limited by the resolution of optical imaging, but also by the practical limitations of the surgical hand. As long as microscopic or robotic surgery is no routine practice, the discussion on the level of resolution will therefore lie within the margin of technical surgical possibilities. In analogy to highly accurate stereotactic radiotherapy using Cyberknife® that has a technical error-margin of 0.5-2 mm,(48) it is very likely that this level of accuracy will be sufficient to adequately treat the patient with minimal unnecessary loss of functionality. 
Challenges for clinical translation
Although a rapidly increasing amount of data is supporting the additional value of optical imageguided surgery for cancer therapy, challenges remain in translation of the preclinical experimental setup into routinely clinical practice. (2, 6) The technique requires development of tumor-specific fluorescence agents and dedicated intraoperative camera systems. Important progress has been made over the last years in both fields, but it is essential to identify the hurdles that are still impeding successful clinical translation.
An intrinsic limitation of development of fluorescence tumor-specific agents is the fact that such drugs are used as diagnostic tools instead of therapeutic drugs that require administration over a longer period of time. Development of diagnostic drugs is therefore subject to lower financial incentives for pharmaceutical companies. The first obvious steps were taken by conjugation of already clinically available tumor-specific agents (e.g. Cetuximab) to fluorophores. (2, 49) Until the technique will become available at a large scale, further development of these agents will have to be performed by non-profit (i.e. academic) organizations.
Furthermore, dedicated imaging systems will have to become easily available for a large group of surgeons to stimulate adoption of the technique. Currently, the most advanced systems are still only available in the research setting of clinical trials, (7, 9) while other systems are already commercially available. (50, 51) These economic and implementation issues are critical for successful adoption of surgical optical imaging.
Research. During fluorescence imaging, the direction of both the excitation light as well as the emitted light is randomized due to scattering. Only a small portion of the excitation light will reach a fluorophore, and only the camera will capture a small portion of the emitted light. As a result, it is often difficult to pinpoint the exact origin of the detected fluorescent signal. 
